Fremanezumab is a humanized monoclonal antibody targeting calcitonin gene–related peptide (CGRP). It is administered monthly via SQ injection.
In this NEJM study, fremanezumab was effective as a preventive treatment for chronic migraine: http://www.nejm.org/doi/full/10.1056/NEJMoa1709038
Subscribe to:
Post Comments (Atom)
-
Dr. Andreas Finner (Trichomed Praxis Berlin) talks about what everyone can do to keep a full head of hair and about the best methods for tre...
No comments:
Post a Comment